Recent advances in nonsurgical management of localized prostate cancer

Affiliations

Yoichi Arai. Int J Clin Oncol. 2007 Dec.

. 2007 Dec;12(6):393-4.

doi: 10.1007/s10147-007-0713-7. Epub 2007 Dec 21.

¹ Department of Urology, Tohoku University Graduate School of Medicine, Sendai, Japan. yarai@uro.med.tohoku.ac.jp

No abstract available

Similar articles

Rising prostate-specific antigen after local therapies have failed: an urgent need for more information.
Sartor O. Sartor O. Clin Prostate Cancer. 2003 Jun;2(1):5-6. doi: 10.3816/cgc.2003.n.007. Clin Prostate Cancer. 2003. PMID: 15046674 No abstract available.
Current status of prostate cancer management in the prostate-specific antigen era.
Sartor O. Sartor O. Clin Prostate Cancer. 2004 Mar;2(4):200-1. doi: 10.3816/cgc.2004.n.001. Clin Prostate Cancer. 2004. PMID: 15072599 No abstract available.
Androgen deprivation and radiation therapy in prostate cancer: the evolving case for combination therapy.
Zietman AL, Shipley WU. Zietman AL, et al. Int J Radiat Oncol Biol Phys. 1997 Jan 15;37(2):245-6. doi: 10.1016/s0360-3016(97)00122-3. Int J Radiat Oncol Biol Phys. 1997. PMID: 9069292 No abstract available.
Treatment for PSA screen-detected prostate cancer: what are the options?
Oliver RT, Neal DE. Oliver RT, et al. Nat Clin Pract Urol. 2009 Mar;6(3):132-4. doi: 10.1038/ncpuro1297. Epub 2009 Jan 27. Nat Clin Pract Urol. 2009. PMID: 19174774 Review. No abstract available.
Expectant management of localized prostate cancer.
Khan MA, Partin AW, Carter HB. Khan MA, et al. Urology. 2003 Nov;62(5):793-9. doi: 10.1016/s0090-4295(03)00653-8. Urology. 2003. PMID: 14624896 Review. No abstract available.